However, the combination of chemotherapy (a single dose of doxorubicin) with following ALK vaccination significantly enhanced the survival of mice challenged intravenously with 1 × 106 ALK-positive lymphoma cells before therapy [53]. The gene discussed is ALK; the disease is lymphoma.